Pfizer defends ‘powerhouse’ Astra deal as CEO braces for grilling

LONDON (Reuters) – Pfizer defended the business case behind its plan to acquire AstraZeneca on Monday and questioned the UK drugmaker’s ability to stand alone for much longer as the New York-based…